Abstract
Conserved protein-carbohydrate-lipid Pathogen Associated Molecular Patterns (PAMPs) interact with cells of the innate immune system to mediate antigen recognition and internalization and activation of immune cells. We examined if analogous ‘biomaterial associated molecular patterns’ composed of proteins, specifically their carbohydrate modifications, existed on biomaterials which can play a role in mediating the innate immune response to biomaterials. To probe for these carbohydrates in the adsorbed protein layer, as directed by the underlying biomaterial chemistry, self-assembled monolayers (SAMs) presenting –CH3, -OH, -COOH or –NH2 were pre-incubated with serum/plasma, and the presence of carbohydrate ligands of C-type Lectin Receptors (CLRs) was investigated using lectin probes in an Enzyme-linked Lectin Assays (ELLA). Presentation of CLR ligands was detected on control tissue culture polystyrene (TCPS). Absorbances of mannose or N-acetylglucosamine increased with decreasing incubating serum concentration; absorbances of sialylated epitopes or fucose remained unchanged. Absorbances of α-galactose or N-acetylgalactosamine decreased with decreasing incubating serum concentration; β-galactose was undetectable. Among SAM endgroups, pre-incubation with 10% serum resulted in differential presentation of CLR ligands; higher α-galactose on COOH SAMs than NH2 or CH3 SAMs, highest complex mannose on NH2 SAMs and higher complex mannose on OH SAMs than CH3 SAMs. Least sialylated groups were detected on CH3 SAMs. In summary, biomaterial chemistry may regulate protein adsorption and hence unique presentation of associated carbohydrates. The ultimate goal is to identify the effects of protein glycosylations associated with biomaterials in stimulating innate immune responses.
Keywords: self-assembled monolayers, pattern recognition receptors, glycoprotein, enzyme linked lectin assay, innate immune response
INTRODUCTION
Glycans are important in mediating various aspects of immune responses such as leukocyte trafficking1, interaction of antigen presenting cells with lymphocytes2, antigen recognition and internalization for antigen processing and presentation3 and direction of adaptive immune responses4. In cancer biology, altered glycosylations of tumor-associated antigens are markers for malignancy5, 6. The extracellular matrix contains glycans within glycosaminoglycans and proteoglycans7, 8 which support tissue structure and sequester growth factors to modulate and direct cell functions9. The potential of glycan/glycoprotein-based materials as biomaterials for tissue engineering are being determined10. The contribution of glycans in the host response to biomaterials remains to be defined.
The innate immune response of neutrophils, monocytes/macrophages and dendritic cells (DCs) to biomaterials is initiated by their recognition of adsorbed cell-adhesive and opsonizing proteins by the cognate receptors [including pattern recognition receptors (PRRs)]. It is this innate response (or foreign body response) to the implanted biomaterial which influences, if not also directs, the “subsequent” immune response to an immunogenic biological component of a combination product primarily through maturation effects on DCs. In this way, the biomaterial may act as an adjuvant, to enhance an adaptive immune response to associated biological antigens. Such an enhancement is desirable for polymeric protein or DNA vaccine delivery systems. However, for a tissue engineering application, not only are we concerned with minimizing fibrous encapsulation of devices, minimizing scar formation and avoiding unwanted cell-mediated implant degradation, but enhancements of adaptive immune responses towards biological components, due to a biomaterial adjuvant effect, are also to be minimized 11-14. A controlled host response to implanted biomaterials is therefore desirable. Although the non-specific host inflammatory response to biomaterials has been examined extensively11-14 with attempts to control it 15-19 the adjuvant effects of biomaterials have only been recently described 20-23 and mechanistic basis elucidated 24-30.
In the innate response to pathogens, innate immune cells use PRRs to recognize conserved epitopes on PAMPs. Among the PRRs, two important families are Toll-like receptors (TLRs) and C-type lectin receptors (CLRs) 3, 31-45. The conserved moieties recognized in PAMPs include bacterial lipopolysaccharide (LPS)46-52, N-acetylglucosamine (GlcNAc) and N-acetylmuraminic acid (MurNAc) in peptidoglycans 46, ß(1-3) glucans in zymosan 31, 53, 54 and mannose-containing bacterial pili55. While the significance of TLR-PAMP interactions in stimulating DC maturation has been well characterized due to nuclear factor-κB (NF-κB) mediated regulation of pro-inflammatory/immunoregulatory genes 35, 36, the role of CLR-mediated recognition, uptake, processing and presentation of carbohydrate antigens has emerged recently 3, 31, 38-43. The CLRs and their carbohydrate ligands in the context of biomaterials have been poorly understood thus far and form the focus of the present work. Dendritic cells play pivotal roles in antigen recognition and processing events 46 and their expression of CLR is broad and well characterized56. However, it is important to note that multiple immune cell types besides DCs including natural killer cells 57 macrophages 58 and neutrophils 59 express PRRs and contribute significantly to shaping innate immune responses to biomaterials through mediating lectin-biomaterial interactions. For example, macrophages express mannose receptor (MR), Endo180, DC-specific ICAM-3 grabbing non-integrin (where ICAM-3 is intercellular adhesion molecule 3) (DC-SIGN), DC-SIGN related (DC-SIGNR) and Dectin-1/β-glucan receptor – the later also expressed by neutrophils 43.
The CLR family has been broadly classified as mannose or galactose binding 43. Examples of CLRs that bind mannose moieties are MR, DC-SIGN 50, and Dectin-1 39, 54. Examples of CLRs that bind α- and/or ß -galactose or GalNAc moieties are asialoglycoprotein receptor (ASGPR) 42 and macrophage galactose N-acetyl-galactosamine (GalNAc) specific lectin 1 (MGL) 60. The carbohydrate binding specificities of different CLRs vary and have been reviewed 49, 50. For example, MR recognized terminal mannose, fucose, sialylated groups or GlcNAc and DC-SIGN recognized mannose-enriched internal residues 41. Carbohydrate recognition by certain CLRs has been linked with endocytosis and processing of cargo 61-63, activation of intracellular signaling mediators and differential downstream immune consequences via ITAM (immunoreceptor tyrosine-based activation motif) 38-40, 54, 61, 63 or ITIM (immunoreceptor tyrosine-based inhibitory motif) 64 residues. Dectin-1 that possesses an ITAM motif and binds β-glucans, has been implicated in the activation of Syk-mediated signaling pathways 39, 54. Furthermore, Dectin-1 has been shown to upregulate TLR 2-mediated activation of NF-κB and exhibit synergism in the regulation of IL-1 and tumor necrosis factor- α (TNF-α) 38.
It is therefore important to characterize the carbohydrate ligands present in the adsorbed protein layer on biomaterial surfaces that may be recognized by CLRs and hence mediate interactions with cells of the innate immune response. The roles of glycans in controlling fundamental immune/inflammatory responses to biomaterials have not been sufficiently studied thus far. It is hypothesized that innate immune cells such as DCs and macrophages may respond to biomaterials by recognizing ‘biomaterial associated molecular patterns’, analogous to PAMPs, through the adsorbed protein layer, specifically through carbohydrate modifications of these proteins using PRRs, to initiate an immune response. Furthermore, innate immune cells may recognize inherent biomaterials through carbohydrates inherent in their structure. To characterize the presence of carbohydrate ligands of CLRs in the adsorbed protein layer, as directed by the underlying surface chemistry, self-assembled monolayers (SAMs) with –CH3, -OH, -COOH, or –NH2 endgroups that present a broad spectrum of well-characterized surface properties such as charge, hydrophobicity/hydrophilicity and chemistry were chosen 65-78. These SAMs were used as model biomaterials to observe the effect of distinct surface chemistries on directing protein adsorption and carbohydrate presentation. An enzyme linked lectin assay (ELLA) was applied to detect carbohydrates, in the adsorbed protein layer, as directed by the distinct SAM surfaces, as recognized by a panel of lectins. Lectins were selected based on their unique specificity for carbohydrate ligands recognized by CLRs. Our specific research interest is on how biomaterial-associated ligands for DCs influence their phenotype. For this purpose, we have previously characterized DC responses to different SAM surfaces, and observed that while OH, COOH or NH2 SAMs triggered modest DC maturation, least maturation was observed on CH3 SAMs. This was likely due to highest immunosuppressive DC apoptosis upon CH3 SAM contact 79. The importance of understanding differential DC responses on different chemistries from the perspective of distinct DC ligands regulated by biomaterial chemistry formed the motivation for this research. This research is also more broadly significant in that it highlights the importance of and begins to define the presence of glycan/glycoproteins in the adsorbed biomolecule layer on biomaterials which may play a role in the recognition of these biomaterials as foreign by innate immune cells to mediate a foreign body response.
METHODS
Self-assembled monolayer preparation
Alkanethiol self-assembled monolayers presenting –CH3, -OH, -COOH or –NH2 chemistries were assembled on 16-well glass chamber slides (LAB-TEK, Nalge Nunc International, Rochester, NY) for carbohydrate or protein measurement assays or on 9 mm × 9 mm glass coverslips for material characterization assays (Bellco Glass, Inc., Vineland, NJ) 71 as described previously 79. The SAMs were allowed to assemble by 12 hr incubation at room temperature (RT) by immersing the Ti/Au-coated slides or coverslips in alkanethiol solutions (1 mM in absolute ethanol), following which the chamber slides or coverslips were washed with 95% ethanol (Sigma, St. Louis, MO), dried with N2 gas (Airgas South, Chamblee, GA) for 10 minutes in a fume hood, equilibrated with Dulbecco’s Phosphate Buffered Saline (PBS) (Invitrogen, Carlsband CA) for 5 minutes at RT and used fresh.
X-ray photoelectron spectroscopy
Characterization of SAMs was performed by low resolution survey scans (spot size 400 μm) or high resolution C1s spectra (spot size 200 μm) X-ray photoelectron spectroscopy (XPS) using a Surface Science model SSX-100 (Surface Sciences Laboratories, Mountain View, CA), with monochromatized AlKα X-rays at 10 kV at the Microelectronic Research Center at Georgia Institute of Technology. Atomic percentages of elements were obtained from low resolution scans and high resolution scan curves were fit based on software provided by the manufacturer, with placement of the hydrocarbon peak at 284.6 eV. Different takeoff-angles of 0°, 20°, 55° or 70° were used (angle between the beam and the normal to the surface) to permit measurements at varying depths from the film surface. The detection limit for angle resolved XPS is ~0.1 atom% in composition and 10-250 Ǻ in depth 29, with maximum and minimum depths attained at takeoff angles of 0° and 90°, respectively. Scans were taken on two spots per sample per take-off angle. Prior to XPS, freshly-prepared SAM samples were washed with 95% ethanol and dried with N2 and analyzed immediately. Theoretical values were determined based on known chemical structure.
Contact angle measurements
Advancing contact angles between freshly-prepared flat SAM and 5 μl drops of de-ionized (DI) H2O were determined in ambient air using a Rame-Hart model # 100-00 goniometer (Mountain Lakes, NJ). For each surface, contact angles were measured for three water droplets, on two sides of each droplet and the values presented denote the average and standard deviations for three measurements in total.
Preparation of heat inactivated human serum or human plasma
Peripheral human blood was obtained from healthy volunteers with informed consent, according to a protocol approved by the Georgia Institute of Technology’s Institute Review Board (IRB) # H05012. Peripheral human blood was collected using sterile 60 mL syringes (Becton Dickinson, Franklin Lakes, NJ) and needles (Becton Dickinson) using heparin (333 U/ mL blood) (Baxter Healthcare Corporation, Deerfield, IL) as an anticoagulant. The clear yellowish human plasma (HP) layer was collected using lymphocyte separation medium (LSM) (Cellgro MediaTech, Herndon, VA) by differential gradient centrifugation of blood diluted 1:1 with sterile PBS (400 g, 30 minutes, RT) (Thermo Fisher Scientific Inc., Waltham, MA) (Model # 5682, Rotor IEC 216). The HP was filtered sterilized (0.22 μm) (Corning, Corning, NY), heat inactivated for 30 minutes in a water bath pre-warmed to 56°C, aliquotted and stored at -20°C. A stock solution of pooled HP from three donors was used for all experiments.
For preparation of human serum (HS), peripheral human blood was collected without heparin. The HS was isolated from non-heparinized blood by centrifugation of blood (3000 rpm, 10 minutes, RT), harvesting the supernatant, pushing down any clots manually using a sterile pipette tip and allowing further clotting (90 minutes, RT) in the tissue culture (TC) hood. Human serum was then cleared by centrifugation (3000 rpm, 15 minutes, RT) after gently pushing down residual precipitates, filter sterilized (0.22 μm) (Corning), heat inactivated for 30 minutes in a water bath pre-warmed to 56°C, aliquotted, and stored at -20°C. A stock solution of pooled HS from the same three donors as used for HP was used for all experiments.
Enzyme linked lectin assay for detection of carbohydrates associated with adsorbed proteins on SAMs or control tissue culture polystyrene (TCPS)
Enzyme Linked Lectin Assays (ELLAs) were performed on SAMs having pre-adsorbed HS or HP proteins using a previously described method with some modifications and optimizations for each lectin 80. The SAMs were incubated with 60 μl/ well of serial half dilutions of HS or HP in PBS starting from 20% down to 2.5% and also dilutions from 1% down to 0.25% (v/ v) or with PBS alone (1 hr, 37°C) in duplicate wells in two chamber slides leading to a total of 4 wells per HS or HP concentration. After aspirating out HS, HP or PBS samples from wells, wells were blocked with 0.5 mg/ mL of freshly prepared bovine serum albumin (BSA) (Sigma) in PBS (block buffer; 1 hr, 37°C), washed three times for 5 minutes each with block buffer at RT and incubated with biotinylated lectin [Narcissus pseudonarcissus (NPA; 12.5 μg/ mL), Sambucus nigra (SNA-1; 12.5 μg/ mL), Ulex europeaus I (UEA-1; 50 μg/ mL), Ulex europaeus II (UEA-2; 12.5 μg/ mL), Pisum sativum (PEA; 25 μg/ mL), Hippeastrum hybrid (HHA; 50 μg/ mL), Peanut agglutinin (PNA; 12.5 μg/ mL), Artocarpus integrifolia (AIA; 25 μg/ mL) or Bauhinia purpurea (BPA; 25 μg/ mL)] with the carbohydrate detection specificities indicated in Table 1 (all from EY Laboratories, Inc., San Mateo, CA)] in block buffer (2 hrs, 37°C). Lectins were selected based on their unique specificity for carbohydrate ligands recognized by CLRs. For UEA-2 lectin, 1.0 mg/ mL heat inactivated BSA (56°C, 30 minutes) in PBS was used in a sensitive blocking step and for PEA or BPA lectins, 1.0 mg/ mL of BSA in PBS was used. Following incubation with the biotinylated lectin, wells were washed and incubated with 10 μg/ mL avidin/alkaline phosphatase (AV/AP) (EY laboratories Inc.) in block buffer (1 hr, 37°C) for detection of bound lectin. The concentration of AV/AP used was 1.25 μg/ mL for SNA-1, PEA or HHA lectins or 20 μg/ mL for AIA or BPA lectins. Finally, wells were washed and incubated with 1.0 mg/ mL p-nitrophenylphosphate (pNPP) (Sigma) substrate for detecting AV/AP (1 hr, 37°C). The solutions were transferred to wells of a clear flat-bottom TCPS treated 96-well plate (Corning) to avoid interference with the reading by SAMs, reaction stopped at RT with 40 μl of 0.4 M NaOH (Sigma) and absorbance read immediately at 405 nm using a SpectraMax Plus 384 plate reader (Molecular Devices, Sunnyvale, CA). Data has been presented after subtracting out the absorbance due to blank. Positive control glycoprotein standard dilutions in PBS (1:1) were run in parallel on TCPS 96-well plates (control) for each lectin; α-2-macroglobulin (from 100 – 12.5 μg/ mL) or (1000 – 3 μg/ mL) for NPA 81 or HHA 82 respectively, glycophorin A (100 – 3 μg/ mL) for SNA-1 83, lactoferrin (1000 – 62.5 μg/ mL) or (1000 – 15 μg/ mL) for UEA-1 84 or PEA respectively, bovine fetuin (1000 – 3 μg/ mL) for UEA-2, asialofetuin (5 – 0.6 μg/ mL) or (31.25 – 1.9 μg/ mL) for PNA 85, 86 or BPA 87 respectively and immunoglobulin A (IgA) (50 – 1.5 μg/ mL) for AIA lectin 88 (all from Sigma), and based on lectin probe specificity data from 89 and in triplicate wells. An identical set of samples (HS or HP) as those run on SAMs were also run on TCPS for each experiment, again in triplicate wells.
Table 1.
Dentritic cell C-type lectin receptors, their corresponding carbohydrate ligands, and carbohydrate specificities for plants lectins used as probes
| C-Type Lectin | Carbohydrate Specificity | Lectin Probe Specificity | Lectin Probe |
|---|---|---|---|
|
| |||
| ASGPR (78) | Galactose | α-galactose | AIA |
|
| |||
| MGL (27, 28; 32; 47) | Gal/N-acetyl-D-galactosamine (GalNAc) (46; 78; 110) | β-galactose | PNA |
|
| |||
| GalNAc | BPA | ||
|
| |||
| MR/MMR (27, 28, 32; 47) | Mannose (27, 28; 32; 47) | Mannose | NPA |
|
| |||
| Fucose (27) | α-L-fucose | UEA-1 | |
|
| |||
| Sialyl Lewis X [sLe(x)], N-acetyl-D-glucosamine (GlcNAc) (33) | NANA (Neu5Acα(2,6) Gal/GalNAc) | SNA-I | |
|
| |||
| GlcNAcβ(1,4) GlcNAc | UEA-II | ||
|
| |||
| DC-SIGN (27, 28; 32; 47) | Mannose | methyl-D-mannopyranoside, D-mannose | PEA |
|
| |||
| Complex mannose residues | mannose α(1,3) and α(1,6) mannose | HHA | |
|
| |||
| sLe(x) (27, 28; 32; 47) | NANA (Neu5Acα(2,6)Gal/GalNAc) | SNA-I | |
|
| |||
| Dectin-1 (27, 28; 32; 47) | β–glucans (27, 28; 32; 47) | GlcNAcβ(1,4) GlcNAc. | UEA-II |
C-type Lectin Receptor Abbreviations: ASGPR, asialogly coprotein receptor; MGL, macrophage galactose N-acetyl-galactosamine specific lectin 1; MR; mannose receptor; DC-SIGN, DC-specific ICAM-3-grabbing non-integrin (where ICAM-3 is intercellular adhesion molecule 3).
Plant Lectin Abbreviations: AIA, Artocarpus integrifolia; PNA, Arachishypogaea; BPA, Bauhinia pupurea; NPA, Narcissus pseudouarcissus; UEA-1, Ulex europaeus; SNA-1, Sambucus nigra; UEA-2, Ulex europaeus-2; PEA, Pisum sativum; HHA, Hippeastrum hybrid.
Enzyme-linked immunosorbent assay (ELISA) for detection of total human immunoglobulin or human serum albumin (HSA)
An enzyme-linked immunosorbent assay (ELISA) was performed to measure amounts of total human IgG 61 or total human serum albumin (HSA) adsorbed from 1% or 10% HS (v/ v) onto SAMs. Self-assembled monolayers were incubated with 60 μl of 1% or 10% (v/ v) HS in PBS (1 hr, 37°C), followed by blocking with 1.0 mg/ mL of BSA in PBS for HSA ELISA or with 0.5 mg/ mL of BSA in PBS for IgG ELISA (both for 1 hr, 37°C) and incubating with 1:10000 dilution of monoclonal mouse anti-HSA (clone HSA-11; IgG2a) (no cross reaction with BSA) or 1:1000 affinity isolated AP-conjugated polyclonal goat anti-human IgG 61 (both from Sigma) (2 hrs, 37°C), for detection of HSA or IgG respectively. Wells were washed three times for 5 minutes each with PBS at RT. For the IgG ELISA, wells were incubated with 1.0 mg/ mL pNPP (30 minutes, RT) after incubating with AP-conjugated primary antibody. For detection of HSA, wells were incubated with 1:1000 dilution of affinity isolated AP-conjugated goat anti-mouse IgG (Sigma) (2 hrs, 37°C), washed and incubated with pNPP substrate (1 hr, RT). The reactions were stopped with 40 μl of 0.4 M NaOH (Sigma) at RT and the solutions transferred to 96-well clear-bottom plates to avoid interference with SAMs and absorbance read at 405 nm using a SpectraMax Plus 384 plate reader (Molecular Devices). Standard curves were generated with 1:10 dilutions of purified IgG or HSA (both from Sigma) in PBS (starting from 100 μg/ mL of IgG or 1 mg/ mL for HSA) on 96-well TCPS control surfaces in triplicate wells. In the same experiment, SAMs were pre-coated with 1% or 10% HS samples and ELISAs were performed to measure amounts of total adsorbed human IgG or HSA (n=2 each) associated with the different SAMs and ELLAs (n=2 each) were also performed using methods described previously to detect carbohydrates present. In this way, to confirm that the varying profiles of carbohydrates observed on different SAMs were in fact different, the ELLA absorbances were normalized to amounts of total human IgG or HSA for the different SAMs, for which both ELLA and ELISA determinations were performed within each experiment and the ratios were compared.
Statistical analysis
Statistical analysis was performed using general linear model analysis of variance with Minitab software (Version 13.20, Minitab Inc., State College, PA) using pairwise comparisons between SAMs, with a Tukey post-test and a p value of less than or equal to 0.05 was considered significant.
RESULTS
Contact angle and XPS characterizations of SAMs showed close agreement with established theoretical values
The SAMs presenting endgroup chemistries –CH3, -OH, -COOH, or –NH2 represented a broad spectrum of surface properties including charge, hydrophobicity/hydrophilicity and chemistry. The CH3 SAMs were hydrophobic and the OH SAMs were neutral, hydrophilic. Under physiological pH conditions (7.2-7.4), the COOH or NH2 SAMs were negatively or positively charged, respectively 66, 71, 90, 91. The SAM surfaces were characterized by XPS analysis (Table 2) and contact angle determination (Table 3). The low resolution XPS survey scans showed agreement with estimated theoretical values for these surfaces and previously published values 76 and indicated modification of Au/Ti surfaces with the alkanethiols with appropriate changes in C1s and O1s percentages as expected. Carbon was the predominant element present for all samples. On control samples coated with Au/Ti alone, no carbon was detected. The percentages of different elements measured were similar to expected values based on theoretical estimates for all samples using take-off angles of 0°, 20°, 55° and 70° for surface analysis at different depths. Overall the SAMs were composed of alkanethiols that presented functional endgroups closest to the exterior and furthest from the Au/Ti substrate to which the alkanethiol chains were anchored (Table 2).
Table 2.
Elemental composition of SAM endgroups presenting different chemistries using variable-angle XPS where angle is calculated from the surface plane; mean ± (range/2), n=2 spots per sample per take-off angle
| SAM | Angle (°) | C1s (%) | O1s (%) | N1s (%) | S2p (%) |
|---|---|---|---|---|---|
| CH3 | 0 | 89.5 ± 3.8 | 12.8 ± 7.2 | ||
| 20 | 86.9 ± 7.0 | 13.0 ± 7.0 | |||
| 55 | 94.6 ± 2.3 | 5.3 ± 2.3 | |||
| 70 | 95.1 ± 0.6 | 4.8 ± 0.6 | |||
| Theoretical | 92.3 | 7.7 | |||
| OH | 0 | 83.6 ± 3.0 | 11.4 ± 3.1 | 4.8 ± 0.1 | |
| 20 | 84.2 ± 5.9 | 11.8 ± 5.0 | 3.9 ± 0.9 | ||
| 55 | 85.4 ± 0.3 | 8.0 ± 1.6 | 6.4 ± 1.3 | ||
| 70 | 83.7 ± 7.3 | 12.2 ± 2.4 | 3.9 ± 4.8 | ||
| Theoretical | 84.6 | 7.7 | 4.1 | ||
| COOH | 0 | 82.5 ± 6.4 | 15.4 ± 4.7 | 2.2 ± 1.8 | |
| 20 | 83.6 ± 0.7 | 9.6 ± 4.3 | 6.7 ± 6.5 | ||
| 55 | 80.1 ± 1.0 | 14.6 ± 1.2 | 5.2 ± 2.2 | ||
| 70 | 81.6 ± 0.0 | 13.6 ± 1.8 | 4.6 ± 1.8 | ||
| Theoretical | 79 | 14 | 7 | ||
| NH2 | 0 | 77.3 ± 3.8 | 8.6 ± 1.5 | 14.0 ± 2.0 | |
| 20 | 87.2 ± 1.3 | 8.5 ± 1.1 | 4.1 ± 2.5 | ||
| 55 | 83.3 ± 7.2 | 10.9 ± 3.7 | 5.6 ± 3.6 | ||
| 70 | 80.3 ± 1.4 | 10.7 ± 6.1 | 8.9 ± 7.5 | ||
| Theoretical | 86 | 7 | 7 |
Table 3.
Advancing contact angles between different SAM endgroups and water droplets in ambient air; mean ± S.D., n=3 water droplets
| SAM | Advancing Angle (°) |
|---|---|
| CH3 | 108 ± 2 |
| OH | 24 ± 5 |
| COOH | 31 ± 3 |
| NH2 | 35 ± 4 |
Advancing contact angles were measured (on both sides of the drop) between 5-μl drops of DI water and glass coverslips coated with Au/Ti, on which the different SAMs were assembled, to measure the degree of hydrophobicity/hydrophilicity of the surface. The contact angle measurements indicated that 11-mercapto-1-undecanol with a terminal hydroxyl group was the most hydrophilic surface and that 1-dodecanethiol, with a terminal methyl group, was the most hydrophobic (Table 3) 66, 71, 90, 91.
Differential ELLA absorbances on different SAMs or control TCPS
The ELLA assays were performed using lectin probes listed in Table 1 to characterize the accessible carbohydrates ligands of CLRs associated with the adsorbed HS or HP proteins on different SAMs. The carbohydrates are described as accessible since they are detectable by lectin binding as far as being available through an appropriate glycoprotein confirmation with lectin recognition of the carbohydrate. On 96-well TCPS surfaces treated as control, standard curves were generated for each lectin-positive control glycoprotein (Figure 1a-h) to confirm assay reproducibility and for each lectin, to demonstrate the relationship between absorbance and carbohydrate amount on the surface. Each glycoprotein was used as a representative typical source of the carbohydrate, but is not the only source of the carbohydrate in HS or HP. In general, absorbances corresponding to the presence of specific carbohydrates decreased when TCPS surfaces were pre-incubated with decreasing HS dilutions in PBS (1:1 dilutions between 20% and 2.5% and also serial half dilutions from 1% down to 0.25%) when probed with BPA (GalNAc) (Figure 2b) or AIA (β-galactose) (Figure 2c) (both in Figure 2a), but no change for PNA (β-galactose) which was undetectable (data not shown), galactose-family lectins. In contrast, pre-incubation of TCPS surfaces with decreasing HS concentrations resulted in increasing absorbances when probed with NPA (mannose) (Figure 3e) or UEA-2 (GlcNAc) (Figure 3d) mannose-family lectins or unchanged absorbances with different HS dilutions for UEA-1 (fucose) (Figure 3c) or SNA-1 (sialylated groups) (Figure 3f) (all in Figure 3a). For PEA (complex mannose) (Figure 3b) high absorbances were detected when TCPS surfaces were pre-incubated with concentrations of 2.5% or 1% HS (intermediate among the range of HS concentrations tested).
Figure 1.

ELLA standard curves for lectin probes using positive control adsorbed glycoproteins on control TCPS surfaces.
Enzyme linked lectin assays were performed using pairs of lectin probe: serial half-dilutions of glycoprotein in PBS on TCPS surfaces; PNA: asialofetuin (a), BPA: asialofetuin (b), AIA: IgA (c), PEA: bovine fetuin (d), UEA-1: lactoferrin (e) UEA-2: bovine fetuin (f), α-2-macroglobulin: NPA (g), glycophorin A: SNA-1 (h), to confirm assay reproducibility and sensitivity. Standard curves were resolved using linear curve fitting routines. mean±SD, representative results of n = 6 independent determinations.
Figure 2.

Trends of α-galactose or GalNAc presence in the adsorbed protein layer on TCPS surfaces with decreasing concentration of pre-incubating HS in PBS.
Enzyme linked lectin assays were performed using plant lectins probes for carbohydrate ligands of ASGPR or MGL, as shown for all lectins together in (a) or separately for each lectin namely N-acetyl-galactosamine (GalNAc) (BPA) (b) or α-galactose (AIA) (c) associated with proteins adsorbed on TCPS pre-incubated with varying concentrations of HS in PBS. Absorbances corresponding to presence of GalNAc (BPA) or α-galactose (AIA) decreased with decreasing concentration of pre-incubating HS. β-galactose (PNA) was undetectable and data is not shown. mean±SD, n = 3 independent determinations, ‘*’: significantly different from HS concentration, p≤ 0.05.
Figure 3.

Trends of mannose or sialylated group presence in the adsorbed protein layer on TCPS surfaces with decreasing concentration of pre-incubating HS in PBS.
Enzyme linked lectin assays were performed using plant lectins probes for carbohydrate ligands of MR, DC-SIGN or Dectin-1, as shown for all lectins together in (a) or separately for each lectin namely complex mannose (PEA) (b), α-fucose (UEA-1) (c), GlcNAc (UEA-2) (d), mannose (NPA) (e) or sialylated groups (SNA-1) (f) associated with proteins adsorbed on TCPS pre-incubated with varying concentrations of HS in PBS. Absorbances corresponding to presence of mannose (NPA), or GlcNAc (UEA-2) increased with decreasing concentration of pre-incubating HS. Absorbances corresponding to the presence of sialylated groups (SNA-1) or α-fucose (UEA-1) remained unchanged across HS dilutions. Absorbance corresponding to presence of complex mannose (PEA) was highest at intermediate concentrations of HS tested. mean±SD, n = 3 independent determinations, ‘*’: significantly different from HS concentration, p≤ 0.05.
Among SAMs, pre-incubation with 1% HS resulted in absorbances that indicated the higher presence of α-galactose on COOH SAMs and NH2 SAMs compared to CH3 SAMs (Figure 4a). On the other hand, pre-incubation with 10% HS, resulted in absorbances that implied higher levels of α-galactose on COOH SAMs than on NH2 or CH3 SAMs (Figure 4b). For all SAMs, β-galactose was undetectable using PNA (data not shown). For SAMs that were pre-incubated with 1% or 10% HS in PBS, highest presence of complex mannose was detected on NH2 SAMs, and OH SAMs had higher absorbances compared to CH3 SAMs (Figure 5). Lowest absorbances corresponding to the presence of sialylated groups were detected on CH3 SAMs (Figure 5).
Figure 4.

Differential presence of α-galactose on different SAMs pre-incubated with 1% or 10% HS.
Enzyme linked lectin assay was performed using plant lectins probes for carbohydrate ligands of ASGPR or MGL namely β-galactose (PNA), n-acetyl-galactosamine (GalNAc) (BPA) or α-galactose (AIA) associated with proteins adsorbed on SAMs pre-incubated with 1% (a) or 10% (b) HS in PBS. Among SAMs, pre-incubated with 1% HS, absorbance corresponding to α-galactose showed trends: COOH or NH2 > CH3 SAMs (a) or with 10% HS in PBS, absorbance corresponding to α-galactose showed trends COOH > NH2 or CH3 SAMs (b), mean±SD, n = 9 independent determinations; ‘*’: significantly different from indicated SAM endgroup, p≤ 0.05.
Figure 5.

Differential presence of sialylated groups or complex mannose on different SAMs pre-incubated with 10% HS.
Enzyme linked lectin assay was performed using plant lectins probes for carbohydrate ligands of MR, DC-SIGN or Dectin-1, namely complex mannose (PEA), α-fucose (UEA-1), GlcNAc (UEA-2), mannose (NPA) or sialylated groups (SNA-1) associated with proteins adsorbed on SAMs pre-incubated with 10% HS in PBS. The CH3 SAMs were associated with absorbances corresponding to least presence of sialylated groups and the NH2 SAMs were associated with absorbances corresponding to highest presence of complex mannose. mean±SD, n = 9 independent determinations; ‘*’: significantly different from indicated SAM endgroup, p≤ 0.05.
In another set of experiments, SAMs were incubated with 1% or 10% HP and similar results were obtained as observed with incubating solutions of 1% or 10% HS, however trends were less defined with HP with both mannose or galactose family lectin probes (data not shown). No differences in ELLA absorbances for sialylated groups were observed following either 1 hr or 24 hrs incubations of 1% or 10% HS on different SAMs (data not shown). Similar results were obtained when 1% or 10% HP or HS was incubated on different SAMs (data not shown), hence there was no effect of incubating HP or HS concentration on ELLA absorbance.
Normalization of ELLA absorbances to protein amounts
The absorbances measured using the ELLA assays were normalized to adsorbed protein amounts (human IgG or HSA) to investigate if the differences in accessible glycosylation profiles across SAM chemistries persisted after accounting for variations in amounts of adsorbed proteins (data not shown). The CH3 SAMs had significantly higher levels of adsorbed IgG compared to COOH SAMs when pre-incubated with 10% HS. Normalized ratios of ELLA absorbance over mean IgG amount indicated similar trends as those observed from non-normalized ELLA absorbances for both mannose and galactose family lectins. Furthermore, since HSA was not detected on all SAMs, normalizations of ELLA absorbances over HSA amounts could not be performed.
DISCUSSION
Differential carbohydrate absorbance profiles corresponding to accessible carbohydrates were observed on SAMs presenting different endgroups, suggesting that different biomaterial chemistries may drive the formation of distinct ‘biomaterial associated molecular patterns’ composed of proteins and carbohydrates. These carbohydrate ligands, present in the adsorbed protein layer on biomaterial surfaces, may be recognized by CLRs and hence mediate interactions with cells of the innate immune response. These results are in agreement with a previous study that demonstrated that different levels of DC maturation were obtained following treatment with the different SAM chemistries used here 79, suggesting that there exists an intricate and highly complex connection between protein-associated molecular patterns on biomaterials and the ensuing DC recognition and activation events.
In this study, incubating concentrations of 1% or 10% pooled heat-inactivated filtered HS or HP were chosen since media in which DCs are cultured in vitro analogously contain 10% heat-inactivated filtered fetal bovine serum (FBS) or 1% autologous heat-inactivated filtered HP 79. When pre-incubated with 10% HS, COOH or NH2 SAMs were associated with higher absorbances corresponding to the presence of α-galactose than CH3 SAMs and undetectable levels of GalNAc (Figure 4b). Pre-incubation with 1% HS resulted in higher α-galactose on COOH SAMs than on CH3 or NH2 SAMs and still undetectable levels of GalNAc (Figure 4a). With incubating solutions of 1% or 10% HS, the NH2 SAMs displayed the highest presence of complex mannose as well as higher complex mannose on OH versus CH3 SAMs (Figure 5). Finally, the CH3 SAMs were associated with least presence of sialylated groups (Figure 5). These results have been summarized in Table 4 and imply that the profile of accessible carbohydrates varied with different types and concentrations of incubating solutions, probably as a result of differential protein adsorption from these solutions. An important caveat is that the absence of lectin binding only suggests that the specific carbohydrate ligand of the lectin probe may not be accessible to the probing lectin, but does not necessarily indicate that the glycan in question is itself not present on the biomaterial surface. However, if the glycan is not accessible to the lectin, it may also not be accessible to the cell receptor.
Table 4.
Summary of results for enzyme-linked lectin assay on polystyrene or SAM endgroups for mannose or galactose family lectins
| Carbohydrate Moiety | Polystyrene | SAM | ||
|---|---|---|---|---|
| Serum | Plasma | 10% Serum | Plasma | |
| Mannose | Increasing absorbance trend with decreasing serum % | No trend | No trend | |
| GlcNAc | Increasing absorbance trend with decreasing serum % | No trend | No trend | |
| Sialylated groups | Increasing absorbance trend with decreasing serum % | Lowest on CH3 SAM | No trend | |
| α-Fucose | No absorbance trend with decreasing serum % | No trend | No trend | |
| Complex mannose | No absorbance trend with decreasing serum % | NH2 SAM > ALL SAM OH > CH3 SAM | No trend | |
| α-Galactose | Decreasing absorbance trend with decreasing serum % | COOH > CH3, NH2 | No trend | |
| β-Galactose | Not Detectable | No trend | No trend | |
| GalNAc | Decreasing absorbance trend with decreasing serum % | Not detectable | Low levels | |
In an attempt to quantify the differences in absorbances, and to confirm that the differential profiles of accessible carbohydrates were in fact different and not solely due to differences in amounts of adsorbed HS or HP proteins, ELLA absorbances were normalized to mean adsorbed IgG or HSA amounts. Consistent trends among profiles of accessible carbohydrates among SAMs were observed for non-normalized and normalized ELLA measurements. It is important to note that since several proteins in HS or HP are glycosylated, in certain cases with multiple glycosylations and linkages, normalization against single proteins such as IgG or HSA (negligible glycosylations) performed in this study, alone, may not be appropriate. A more optimal normalization method for future studies would be to quantify biomaterial adsorption of a panel of relevant glycosylated proteins. It is worth noting that adsorbed HSA may not have been detected on the SAMs due to the conformational sensitivity of the monoclonal antibody against HSA, since the protein may have adsorbed in different conformations on the different SAMs. Another possibility is that the absence of detected HSA may be due to a lack of antibody recognition for the heat-denatured albumin, since heat-denatured serum/plasma was used.
In this study, SAMs having -CH3, OH, -COOH or -NH2 chemistries were used as model biomaterials to examine the profiles of accessible carbohydrates associated with adsorbed HS or HP proteins. The XPS (Table 2) and contact angle (Table 3) characterizations of the SAM endgroups in this study revealed close agreement with previous studies 66, 72, 90, 91 and showed a broad spectrum of surface properties. Differences in amounts and conformations of adsorbed proteins have been observed on SAMs with endgroups. Variations in antibody binding affinities against the cell binding domain of fibronectin were observed on different SAM endgroups 70, 71, 92. Furthermore, significantly higher amounts of pro-inflammatory fibrinogen were adsorbed to OH SAMs than to CH3 SAMs 93, although others have found otherwise 75, 76, 77, 94. It was observed that higher amounts of pro-inflammatory complement-3 (C3) 95 was measured on OH SAMs than on CH3 SAMs, although highest amounts of human IgG were detected on CH3 SAMs compared to OH, COOH or NH2 SAMs 96. In contrast, adsorption of anti-inflammatory protein albumin was higher on CH3 SAMs compared to either OH or COOH SAMs 97.
Similar to the pro- or anti-inflammatory roles ascribed to differed HS or HP proteins such as C3 or albumin respectively, we speculate that carbohydrates associated with these proteins may also have pro- or anti-inflammatory effects. On 96-well TCPS surfaces that served as experimental controls, several carbohydrates probed for were associated with differential absorbance patterns following pre-incubations with different concentrations of HS or HP in PBS (1: 1 dilutions between 20% and 2.5% and 1% and 0.25%) (Figures 2 and 3). In general, trends indicated increasing absorbances for certain mannose group carbohydrates (GlcNAc or mannose) on TCPS (Figure 3) with decreasing HS concentrations, suggesting that higher presentation of these carbohydrates occurred with decreasing levels of other ‘masking’ proteins. A notable contrast was observed for galactose group carbohydrates (α-galactose or GalNAc) on TCPS (Figure 2), where increasing absorbances corresponded to increased presence of these carbohydrates with increasing HS concentrations. These results offer indirect support to literature that has implied opposing roles for mannose or galactose family proteins in stimulating immune responses. In tumor glycans that have high levels of exposed galactose moieties following de-sialylation of O-glycans, the galactose molecules were recognized by MGL, leading to the induction of tumor tolerance in the absence of TLR signaling 60. While galactose binding to CLRs has been linked to anti-inflammatory effects, ligand binding to MR may result in pro-inflammatory effects, since blocking of MR inhibited the fusion of macrophages to form foreign body giant cells (FBGCs) 98, although others have reported observing both pro- and anti-inflammatory effects depending on the nature of the MR ligand 99. Taken together, the emerging model of PRRs and their ligands indicates that the specific carbohydrate ligand bound is important, since the same or different carbohydrate ligands may target a different complex network of DC CLRs and other PRRs and hence trigger differential DC responses. It may therefore be of importance to further characterize the pro/anti-inflammatory roles of the carbohydrate ligands presented by biomaterials, given these findings.
A clear link also exists in the literature between altered glycosylations and disease progression 100-102. While normal host proteins have relatively low terminal mannose, fucose or GlcNAc 43, 103, disease states are associated with alterations in protein glycosylations. Tumors have been associated with increased sialylation, mannosylation, fucosylation 104 and reduction in O-glycan lengths 105, 106. Liver disease is associated with lowered sialylation and increased glycan branching 104, 105 and rheumatoid arthritis by increased fucosylation and presence of sialyl Lewis X on alpha-1-acid glycoprotein 107, 108. Finally, it was observed that immature DCs expressing DC-SIGN (but not mature DCs) interacted with carcinoembryonic antigen having higher Lewis x or Lewis y Ag levels on colon epithelial tumor cells than on normal cells 109-111. Another line of speculation therefore, is that if the proteins adsorbed to the biomaterial have undergone conformational changes as reported previously 71 and hence present an altered profile of exposed carbohydrates, the biomaterial may appear analogous to diseased states to circulating immune cells, including migrating DCs.
These results suggest that biomaterials presenting different surface chemistries differentially modulate carbohydrate presentation in the adsorbed protein layers, possibly due to differences in types or amounts (or both) of adsorbed proteins. Glycosylations in PAMPs or altered glycosylations in diseases initiate DC recognition, and in the same way, glycosylations presented by biomaterials may impact DC maturation in a CLR-mediated manner. Future studies are aimed at determining the contribution of glycans/glycoproteins to DC recognition and responses to biomaterials and adsorbed protein sources of glycosylations. This study is significant as it provides another class of biomolecules which may mediate innate immune cell interactions with a biomaterial and can influence the host response to the material.
Acknowledgments
This research was funded by the National Science Foundation under a CAREER grant (BES-0239152) and a National Institutes of Health (NIH) grant (1RO1 EB004633-01A1). The authors thank Jeffrey Capadona of Georgia Tech for supplying the Au/Ti-coated substrates for SAM assembly. The authors also thank Dr. Brani Vidakovic from Georgia Tech for assistance with statistical analysis and Dr. John L. Brash from McMaster University, Hamilton, Canada for several helpful discussions.
References
- 1.Yago T, Leppanen A, Qiu H, Marcus WD, Nollert MU, Zhu C, Cummings RD, McEver RP. Distinct molecular and cellular stabilizing selectin-mediated rolling under flow. J Cell Bio. 2002;158:787–799. doi: 10.1083/jcb.200204041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Geijtenbeek TBH, Torensma R, van Vliet SJ, van Duijnhoven GCF, Adema GJ, van Kooyk Y, Figdor CG. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 2000;100:575–585. doi: 10.1016/s0092-8674(00)80693-5. [DOI] [PubMed] [Google Scholar]
- 3.Engering A, Geijtenbeek TBH, Van Kooyk Y. Immune escape through C-type lectins on dendritic cells. Trends in Immunol. 2002;23:480–485. doi: 10.1016/s1471-4906(02)02296-2. [DOI] [PubMed] [Google Scholar]
- 4.Gringhuis SI, Den Dunnen J, Litjens M, van het Hof B, van Kooyk Y, Geijtenbeek BH. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity. 2007;26:605–616. doi: 10.1016/j.immuni.2007.03.012. [DOI] [PubMed] [Google Scholar]
- 5.Liu XE, Desmyter L, Gao CF, Laroy W, Dewaele S, Vanhooren V, Wang L, Zhuang H, Callewaert N, Libert C, Contreras R, Chen C. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology. 2007;46:1426–1435. doi: 10.1002/hep.21855. [DOI] [PubMed] [Google Scholar]
- 6.Fujimura T, Shinohara Y, Tissot B, Pang PC, Kurogohi M, Saito S, Arai Y, Sadilek M, Murayama K, Dell A, Nishimura S, Hakomori SI. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects. Inter J Cancer. 2008;122:39–49. doi: 10.1002/ijc.22958. [DOI] [PubMed] [Google Scholar]
- 7.Yung S, Chan TM. Peritoneal proteoglycans: much more than ground substance. Perit Dial Int. 2007;27:375–390. [PubMed] [Google Scholar]
- 8.Roughley PJ. The structure and function of cartilage proteoglycans. European Cells Materials. 2006;12:92–101. doi: 10.22203/ecm.v012a11. [DOI] [PubMed] [Google Scholar]
- 9.Macri L, Silverstein D, Clark RA. Growth factor binding to the pericellular matrix and its importance in tissue engineering. Adv Drug Deliv Rev. 2007;59:1366–1381. doi: 10.1016/j.addr.2007.08.015. [DOI] [PubMed] [Google Scholar]
- 10.Ferdous Z, Grande-Allen KJ. Utility and control of proteoglycans in tissue engineering. Tissue Eng. 2007;13:1893–1904. doi: 10.1089/ten.2006.0056. [DOI] [PubMed] [Google Scholar]
- 11.Babensee JE, Anderson JM, McIntire LV, Mikos AG. Host response to tissue engineered devices. Adv Drug Deliv Rev. 1998;33(1-2):111–139. doi: 10.1016/s0169-409x(98)00023-4. [DOI] [PubMed] [Google Scholar]
- 12.Babensee JE, Sefton MV. Viability of HEMA-MMA microencapsulated model hepatoma cells in rats and the host response. Tissue Eng. 2000;6(2):165–182. doi: 10.1089/107632700320784. [DOI] [PubMed] [Google Scholar]
- 13.Rihova B. Immunocompatibility and biocompatibility of cell delivery systems. Adv Drug Deliv Rev. 2000;42(1-2):65–80. doi: 10.1016/s0169-409x(00)00054-5. [DOI] [PubMed] [Google Scholar]
- 14.Tang L, Eaton JW. Inflammatory response to biomaterials. Am J Clin Pathol. 1995;103(4):466–471. doi: 10.1093/ajcp/103.4.466. [DOI] [PubMed] [Google Scholar]
- 15.Kyriakides TR, Leach KJ, Hoffman AS, Ratner BD. Mice that lack the angiogenesis inhibitor thrombospondin 2 mount an altered foreign body reaction characterized by increased vascularity. Proc Natl Acad Sci USA. 1999;96(8):4449–4454. doi: 10.1073/pnas.96.8.4449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Picha GJ, Drake RF. Pillard-surface microstructure and soft-tissue implants: Effect of implant site and fixation. J Biomed Mater Res. 1996;30:305–312. doi: 10.1002/(SICI)1097-4636(199603)30:3<305::AID-JBM5>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
- 17.Sanders JE, Baker AB, Golledge SL. Control of in vivo microvessel ingrowth by modulation of biomaterial local architecture and chemistry. J Biomed Mater Res A. 2002;60(1):36–43. doi: 10.1002/jbm.1279. [DOI] [PubMed] [Google Scholar]
- 18.Brauker JH, Carr-Brendel VE, Martinson LA, Crudele J, Johnston WD, Johnson RC. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res A. 1995;29(12):1517–1524. doi: 10.1002/jbm.820291208. [DOI] [PubMed] [Google Scholar]
- 19.van Luyn MJ, Khouw IM, van Wachem PB, Blaauw EH, Werkmeister JA. Modulation of the tissue reaction to biomaterials. II. The function of T cells in the inflammatory reaction to crosslinked collagen implanted in T-cell-deficient rats. J Biomed Mater Res A. 1998;39(3):398–406. doi: 10.1002/(sici)1097-4636(19980305)39:3<398::aid-jbm8>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- 20.Ertl HC, Varga I, Xiang ZQ, Kaiser K, Stephens L, Otvos LJ. Poly(DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines. Vaccine. 1996;14(9):879–885. doi: 10.1016/0264-410x(96)00005-9. [DOI] [PubMed] [Google Scholar]
- 21.Walker KB, Xing DKL, Sesardic D, Corbel MJ. Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres. Dev Biol Stand. 1998;92:259–267. [PubMed] [Google Scholar]
- 22.Matzelle MM, Babensee JE. Humoral and T cell immune responses to model antigen delivered with biomaterials used in tissue engineering. Biomaterials. 2004;25(2):295–304. doi: 10.1016/s0142-9612(03)00531-3. [DOI] [PubMed] [Google Scholar]
- 23.Bennewitz NL, Babensee JE. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen. Biomaterials. 2005;26(16):2991–2999. doi: 10.1016/j.biomaterials.2004.08.023. [DOI] [PubMed] [Google Scholar]
- 24.Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 1997;388(6644):782–787. doi: 10.1038/42030. [DOI] [PubMed] [Google Scholar]
- 25.Sun H, Pollock KG, Brewer JM. Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro. Vaccine. 2003;21(9-10):849–855. doi: 10.1016/s0264-410x(02)00531-5. [DOI] [PubMed] [Google Scholar]
- 26.Singh M, O’Hagan D. Advances in vaccine adjuvants. Nat Biotechnol. 1999;17(11):1075–1081. doi: 10.1038/15058. [DOI] [PubMed] [Google Scholar]
- 27.Yoshida M, Babensee JE. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res A. 2004;71(1):45–54. doi: 10.1002/jbm.a.30131. [DOI] [PubMed] [Google Scholar]
- 28.Babensee JE, Paranjpe A. Differential levels of dendritic cell maturation on different biomaterials used in combination products. J Biomed Mater Res A. 2005;74(4):503–10. doi: 10.1002/jbm.a.30429. [DOI] [PubMed] [Google Scholar]
- 29.Yoshida M, Babensee JE. Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation. J Biomed Mater Res A. 2006;79(2):393–408. doi: 10.1002/jbm.a.30798. [DOI] [PubMed] [Google Scholar]
- 30.Yoshida M, Babensee JE. Molecular aspects of microparticle phagocytosis by dendritic cells. J Biomater Sci Polym Ed. 2006;17(8):893–907. doi: 10.1163/156856206777996844. [DOI] [PubMed] [Google Scholar]
- 31.Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature. 2001;413(6851):36–37. doi: 10.1038/35092620. [DOI] [PubMed] [Google Scholar]
- 32.Bhardwaj N. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J Clin Invest. 1994;94(2):797–807. doi: 10.1172/JCI117399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J Immunol. 2001;167(5):2887–2894. doi: 10.4049/jimmunol.167.5.2887. [DOI] [PubMed] [Google Scholar]
- 34.Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF., III The extra domain of fibronectin activates toll-like receptor 4. J Biol Chem. 2001;276(13):10229–10233. doi: 10.1074/jbc.M100099200. [DOI] [PubMed] [Google Scholar]
- 35.Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2(8):675–680. doi: 10.1038/90609. [DOI] [PubMed] [Google Scholar]
- 36.Medzhitov R, Janeway CAJ. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001;1(2):135–145. doi: 10.1038/35100529. [DOI] [PubMed] [Google Scholar]
- 37.Aderem A, Ulevitch RJ. Toll-like Receptors in the induction of the innate immune response. Nature. 2000;406(6797):782–787. doi: 10.1038/35021228. [DOI] [PubMed] [Google Scholar]
- 38.Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med. 2003;197(9):1107–1117. doi: 10.1084/jem.20021787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Rogers NC, Slack EC, Edwards AD, Nolte MA, Schulz O, Schweighoffer E, Williams DL, Gordon S, Tybulewicz VL, Brown GD, Reis E, Sousa C. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity. 2005;22(4):507–17. doi: 10.1016/j.immuni.2005.03.004. [DOI] [PubMed] [Google Scholar]
- 40.Dillon S, Agrawal S, Banerjee K, Letterio J, Denning TL, Oswald-Richter O, Kasprowicz DJ, Kellar K, Pare J, van Dyke T, Ziegler S, Unutmaz D, Pulendran B. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest. 2006;116(4):916–928. doi: 10.1172/JCI27203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Geitjenbeek TBH, Engering A, van Kooyk Y. DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology. J Leukoc Biol. 2002;71(6):921–931. [PubMed] [Google Scholar]
- 42.Valladeau J, Duvert-Frances V, Pin JJ, Kleijmeer MJ, Ait-Yahia S, Ravel O, Vincent C, Veha JF, Helms A, Gorman D, Zurawski SM, Zurawski G, Ford J, Saeland S. Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J Immunol. 2001;167(10):5767–5774. doi: 10.4049/jimmunol.167.10.5767. [DOI] [PubMed] [Google Scholar]
- 43.McGreal EP, Martinez-Pomares L, Gordon S. Divergent roles for C-type lectins expressed by cells of the innate immune system. Mol Immunol. 2004;41(11):1109–1121. doi: 10.1016/j.molimm.2004.06.013. [DOI] [PubMed] [Google Scholar]
- 44.Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P, Simon JC. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol. 2000;165(4):1863–1887. doi: 10.4049/jimmunol.165.4.1863. [DOI] [PubMed] [Google Scholar]
- 45.Termeer CC, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake F, Freudenberg M, Galanos C, Simon JC. Oligosaccharides of hyaluronan activate dendritc cells via toll-like receptor 4. J Exp Med. 2002;195(1):99–111. doi: 10.1084/jem.20001858. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245–252. doi: 10.1038/32588. [DOI] [PubMed] [Google Scholar]
- 47.Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811. doi: 10.1146/annurev.immunol.18.1.767. [DOI] [PubMed] [Google Scholar]
- 48.Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: Endogenous activators of dendritic cells. Nat Med. 1999;5(11):1249–1255. doi: 10.1038/15200. [DOI] [PubMed] [Google Scholar]
- 49.Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol. 2002;2(2):77–84. doi: 10.1038/nri723. [DOI] [PubMed] [Google Scholar]
- 50.van Kooyk Y, Geitjenbeek TBH. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol. 2003;3(9):697–709. doi: 10.1038/nri1182. [DOI] [PubMed] [Google Scholar]
- 51.Pulendran B. Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol Rev. 2004;199:227–250. doi: 10.1111/j.0105-2896.2004.00144.x. [DOI] [PubMed] [Google Scholar]
- 52.Janeway CAJ, Medzhitov R. Innate Immune Recognition. Annu Rev Immunol. 2002;20:197–216. doi: 10.1146/annurev.immunol.20.083001.084359. [DOI] [PubMed] [Google Scholar]
- 53.Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S. Dectin-1 mediates the biological effects of beta glucans. J Exp Med. 2003;197(9):1119–1124. doi: 10.1084/jem.20021890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Brown GD. Dectin-1: a signaling non-TLR pattern recognition receptor. Nat Rev Immunol. 2006;6(1):33–43. doi: 10.1038/nri1745. [DOI] [PubMed] [Google Scholar]
- 55.Silverblatt FJ, Ofek I. Interaction of bacterial pili and leukocytes. Infection. 1983;11(4):235–238. doi: 10.1007/BF01641208. [DOI] [PubMed] [Google Scholar]
- 56.van Vliet SJ, den Dunnen J, Gringhuis SI, Geijtenbeek THB, van Kooyk Y. Innate signaling and regulation of Dendritic cell immunity. Curr Opinion Immunol. 2007;19:435–440. doi: 10.1016/j.coi.2007.05.006. [DOI] [PubMed] [Google Scholar]
- 57.Spreu J, Kienle EC, Schrage B, Steinle A. CLEC2A: a novel, alternatively spliced and skin-associated member of the NKC-encoded AICL-CD69-LLT1 family. Immunogenetics. 2007;59(12):903–12. doi: 10.1007/s00251-007-0263-1. [DOI] [PubMed] [Google Scholar]
- 58.Werling D, Hope JC, Howard CJ, Jungi TW. Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists. Immunology. 2004;111:41–52. doi: 10.1111/j.1365-2567.2003.01781.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Taylor PR, Brown GD, Reid DM, Willmet JA, Martinez-Pomares L, Gordon S, Wong SY. The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol. 2002;169:3876–3882. doi: 10.4049/jimmunol.169.7.3876. [DOI] [PubMed] [Google Scholar]
- 60.van Villet SJ, van Liempt E, Saeland E, Aarnoudse CA, Applemelk B, Irimura T, Geitjenbeek TBH, Blixt O, Alvarez R, van Die I, van Kooyk Y. Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor Ags by dendritic cells. Int Immunol. 2005;17(5):661–669. doi: 10.1093/intimm/dxh246. [DOI] [PubMed] [Google Scholar]
- 61.Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM, Nussenzweig MC. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature. 1995;375(6527):151–155. doi: 10.1038/375151a0. [DOI] [PubMed] [Google Scholar]
- 62.Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M, Steinman RM. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol. 2000;151(3):673–684. doi: 10.1083/jcb.151.3.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Cobb BA, Wang Q, Tzianabos AO, Kasper DL. Polysaccharide processing and presentation by the MHCII pathway. Cell. 2004;117(5):677–687. doi: 10.016/j.cell.2004.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Kanazawa N, Okazaki T, Nishimura H, Tashiro K, Inaba K, Miyachi Y. DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif. J Invest Dermatol. 2002;118(2):261–266. doi: 10.1046/j.0022-202x.2001.01633.x. [DOI] [PubMed] [Google Scholar]
- 65.Mrksich M, Chen CS, Xia Y, Dike LE, Ingber DE, Whitesides GM. Controlling cell attachment on contoured surfaces with self-assembled monolayers of alkanethiolates on gold. Proc Natl Acad Sci USA. 1996;93(20):10775–10778. doi: 10.1073/pnas.93.20.10775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Sigal GB, Mrksich M, Whitesides GM. Effect of surface wettability on the adsorption of proteins and detergents. J Am Chem Soc. 1998;120:3464–3473. [Google Scholar]
- 67.Michael KE, Vernekar VN, Keselowsky BG, Meredith JC, Latour RA, Garcia AJ. Adsorption-induced conformational changes in fibronectin due to interactions with well-defined surface chemistries. Langmuir. 2003;19:8033–8040. [Google Scholar]
- 68.Luk Y, Kato M, Mrksich M. Self-Assembled monolayers of alkanthiolates presenting mannitol groups are inert to protein adsorption and cell attachment. Langmuir. 2000;16:9604–9608. [Google Scholar]
- 69.Harder P, Grunze M, Dahint R, Whitesides GM, Laibinis PE. Molecular conformation on oligo (ethylene glycol)-terminated self-assembled monolayers on gold and silver surfaces determines their ability to resist protein adsorption. J Phys Chem B. 1998;102:426–436. [Google Scholar]
- 70.McClary KB, Ugarova T, Grainger DW. Modulating fibroblast adhesion, spreading and proliferation using self-assembled monolayer films of alkylthiolates on gold. J Biomed Mater Res. 2000;50(3):428–439. doi: 10.1002/(sici)1097-4636(20000605)50:3<428::aid-jbm18>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
- 71.Keselowsky BG, Collard DM, Garcia AJ. Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion. J Biomed Mater Res A. 2003;66(2):247–259. doi: 10.1002/jbm.a.10537. [DOI] [PubMed] [Google Scholar]
- 72.Barbosa JN, Barbosa MA, Aguas AP. Adhesion of human leukocytes to biomaterials: An in vitro study using alkanethiolate monolayers with different chemically functionalized surfaces. J Biomed Mater Res A. 2003;65(4):429–434. doi: 10.1002/jbm.a.10488. [DOI] [PubMed] [Google Scholar]
- 73.Schwendel D, Hayashi T, Dahint R, Pertsin A, Grunze M, Steitz R, Schreiber F. Interaction of water with self-assembled monolayers: neutron reflectivity measurements of the water density in the interface region. Langmuir. 2003;19:2284–2293. [Google Scholar]
- 74.Lindbald M, Lestelius M, Johansson A, Tengvall P, Thomsen P. Cell and soft tissue interactions with methyl- and hydroxyl-terminated alkane thiols on gold surfaces. Biomaterials. 1997;18(15):1059–1068. doi: 10.1016/s0142-9612(97)00029-x. [DOI] [PubMed] [Google Scholar]
- 75.Tegoulia VA, Cooper SL. Leukocyte adhesion on model surfaces under flow: effects of surface chemistry, protein adsorption, and shear rate. J Biomed Mater Res. 2000;50(3):291–301. doi: 10.1002/(sici)1097-4636(20000605)50:3<291::aid-jbm2>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
- 76.Shen M, Horbett TA. The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces. J Biomed Mater Res. 2001;57(3):336–345. doi: 10.1002/1097-4636(20011205)57:3<336::aid-jbm1176>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- 77.Kalltorp M, Oblogina S, Jacobsson S, Karlsson A, Tengvall P, Thomsen P. In vivo cell recruitment, cytokine release and chemiluminescence response at gold, and thiol functionalized surfaces. Biomaterials. 1999;20(22):2123–37. doi: 10.1016/s0142-9612(99)00115-5. [DOI] [PubMed] [Google Scholar]
- 78.Dadsetan M, Jones JA, Hiltner A, Anderson JM. Surface chemistry mediates adhesive structure, cytoskeletal organization, and fusion of macrophages. J Biomed Mater Res A. 2004;71(3):439–448. doi: 10.1002/jbm.a.30165. [DOI] [PubMed] [Google Scholar]
- 79.Shankar SP, Keselowsky BG, Garcia AJ, Babensee JE. Glycoprotein-mediated interactions of dendritic cells with biomaterials. Part 1. Dendritic cell responses to SAM endgroups and underlying mechanism. Manuscript Submitted to J Biomed Mater Res. [Google Scholar]
- 80.Leriche V, Sibille P, Carpentier B. Use of an enzyme-linked lectinsorbent assay to monitor the shift in polysaccharide composition in bacterial biofilms. Appl Environ Microbiol. 2000;66(5):1851–1856. doi: 10.1128/aem.66.5.1851-1856.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.van Leuven F, Torrekens S, Van Damme E, Peumans W, Van den Berghe H. Mannose-specific lectins bind alpha-2-macroglobulin and an unknown protein from human plasma. Protein Sci. 1993;2(2):255–63. doi: 10.1002/pro.5560020214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Balzarini J, Van Laethem K, Hatse S, Froeyen M, Van Damme E, Bolmstedt A, Peumans W, De Clercq E. Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis. Mol Pharmacol. 2005;67(5):1556–1565. doi: 10.1124/mol.104.005082. [DOI] [PubMed] [Google Scholar]
- 83.Shibuya N, Goldstein IJ, Broekaertg WF, Nsimba-Lubaki M, Peetersll P, Peumans WJ. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J Biol Chem. 1987;262(4):1596–1601. [PubMed] [Google Scholar]
- 84.De Carlos A, Caride-Castro A, Martinez-Zorzano VS, De La Cadena MP, Rodriguez-Berrocal FJ. Lectin isolation and detection of N-glycoproteins bearing sialic acid and L-fucose residues in human colorectal mucosa and in adenocarcinoma biopsies. Int J Oncol. 2002;20(2):367–372. [PubMed] [Google Scholar]
- 85.Chacko BK, Appukuttan PS. Peanut (Arachis hypogaea) lectin recognizes α-linked galactose, but not N-acetyl lactosamine in N-linked oligosaccharide terminals. Int J Biol Macromol. 2001;28(5):365–371. doi: 10.1016/s0141-8130(01)00139-8. [DOI] [PubMed] [Google Scholar]
- 86.Balu K, Chacko PS. Peanut (Arachis hypogaea) lectin recognizes α-linked galactose, but not N-acetyl lactosamine in N-linked oligosaccharide terminals. Int J Biol Macromol. 2001;28:365–371. doi: 10.1016/s0141-8130(01)00139-8. [DOI] [PubMed] [Google Scholar]
- 87.Sueyoshi S, Tsuji T, Osawa T. Carbohydrate-binding specificities of five lectins that bind to O-glycosyl-linked carbohydrate chains. Quantitative analysis by frontal-affinity chromatography. Carbohydrate Res. 1988;178:213–224. doi: 10.1016/0008-6215(88)80113-7. [DOI] [PubMed] [Google Scholar]
- 88.Roque-Barreira MC, Campos-Neto A. Jacalin: An IgG-binding lectin. J Immunol. 1985;134(3):1740–1743. [PubMed] [Google Scholar]
- 89.van Damme EJM, Peumans WJ, Pusztai A, Bardocz S. Handbook of plant lectins: properties and biomedical applications. 1998 [Google Scholar]
- 90.Tanahashi M, Matsuda T. Surface functional group dependence on apatite formation on self- assembled monolayers in a simulated body fluid. J Biomed Mater Res. 1997;34(3):305–315. doi: 10.1002/(sici)1097-4636(19970305)34:3<305::aid-jbm5>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
- 91.Franco M, Nealey PF, Campbell S, Teixeira AI, Murphy CJ. Adhesion and proliferation of corneal epithelial cells on self assembled monolayers. J Biomed Mater Res. 2000;52(2):261–269. doi: 10.1002/1097-4636(200011)52:2<261::aid-jbm4>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
- 92.Capadona J, Collard D, Garcia AJ. Fibronectin adsorption and cell adhesion to mixed monolayers of tri(ethylene glycol)- and methyl-terminated alkanethiols. Langmuir. 2003;19(5):1847–1857. [Google Scholar]
- 93.Silver JH, Hergenrother RW, Lin JC, Lim F, Lin HB, Okada T, Chaudhury MK, Cooper SL. Surface and blood-contacting properties of alkylsiloxane monolayers supported on silicone rubber. J Biomed Mater Res. 1995;29(4):535–548. doi: 10.1002/jbm.820290414. [DOI] [PubMed] [Google Scholar]
- 94.Rodrigues SN, Goncalves IC, Martins MC, Barbosa MA, Ratner BD. Fibrinogen adsorption, platelet adhesion and activation on mixed hydroxyl-/methyl-terminated self-assembled monolayers. Biomaterials. 2006;27(31):5357–5367. doi: 10.1016/j.biomaterials.2006.06.010. [DOI] [PubMed] [Google Scholar]
- 95.Hirata I, Hioki Y, Toda M, Kitazawa T, Murakami Y, Kitano E, Kitamura H, Ikada Y, Iwata H. Deposition of complement protein C3b on mixed self-assembled monolayers carrying surface hydroxyl and methyl groups studied by surface plasmon resonance. J Biomed Mater Res A. 2003;66(3):669–76. doi: 10.1002/jbm.a.10067. [DOI] [PubMed] [Google Scholar]
- 96.Silin VV, Weetall H, Vanderah DJ. SPR Studies of the Nonspecific Adsorption Kinetics of Human IgG and BSA on Gold Surfaces Modified by Self-Assembled Monolayers (SAMs) J Colloid Interface Sci. 1997;185(1):94–103. doi: 10.1006/jcis.1996.4586. [DOI] [PubMed] [Google Scholar]
- 97.Martins MC, Fonseca C, Barbosa MA, Ratner BD. Albumin adsorption on alkanethiols self-assembled monolayers on gold electrodes studied by chronopotentiometry. Biomaterials. 2003;24(21):3697–706. doi: 10.1016/s0142-9612(03)00244-8. [DOI] [PubMed] [Google Scholar]
- 98.McNally AK, DeFife KM, Anderson JM. Interleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activity. Am J Clin Pathol. 1996;149(3):975–985. [PMC free article] [PubMed] [Google Scholar]
- 99.Chieppa M, Bianchi G, Doni A, Del Prete A, Sironi M, Laskarin G, Monti P, Piemonti L, Biondi A, Mantovani A, Introna M, Allavena P. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J Immunol. 2003;171(9):4552–4560. doi: 10.4049/jimmunol.171.9.4552. [DOI] [PubMed] [Google Scholar]
- 100.Patwa TH, Zhao J, Anderson MA, Simeone DM, Lubman DM. Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection. Anal Chem. 2006;78(18):6411–6421. doi: 10.1021/ac060726z. [DOI] [PubMed] [Google Scholar]
- 101.Kanoh Y, Mashiko T, Danbara M, Takayama Y, Ohtani S, Imasaki T, Abe T, Akahoshi T. Analysis of the oligosaccharide chain of human serum immunoglobulin G in patients with localized or metastatic cancer. Oncology. 2004;66(5):365–370. doi: 10.1159/000079484. [DOI] [PubMed] [Google Scholar]
- 102.Johnson PJ, Poon TCW, Hjelm NM, Ho CS, Blake C, Ho SKW. Structures of disease-specific serum alpha-fetoprotein isoforms. Br J Cancer. 2000;83(10):1330–1337. doi: 10.1054/bjoc.2000.1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Lee RT, Ichikawa Y, Fay M, Drickhamer K, Shao MC, Lee YC. Ligand-binding characteristics of rat serum-type mannose binding protein (MBP-A). Homology of binding site architecture with mammalian and chicken hepatic lectins. J Biol Chem. 1991;266(8):4810–4815. [PubMed] [Google Scholar]
- 104.Tabares G, Radcliffe CM, Barrabes S, Ramirez M, Aleixandre N, Hoesel W, Dwek RA, Rudd PM, Peracaula R, de Llorens R. Different glycan structures in prostrate-specific antigen from prostrate cancer sera in relation to seminal plasma PSA. Glycobiology. 2006;16(2):132–145. doi: 10.1093/glycob/cwj042. [DOI] [PubMed] [Google Scholar]
- 105.Turner G. N-glycosylation of serum proteins in disease and its investigation using lectins. Clin Chim Acta. 1992;208(3):149–171. doi: 10.1016/0009-8981(92)90073-y. [DOI] [PubMed] [Google Scholar]
- 106.Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta. 1999;1473(1):67–95. doi: 10.1016/s0304-4165(99)00170-1. [DOI] [PubMed] [Google Scholar]
- 107.Elliott MA, Elliott HG, Ghallagher K, McGuire J, Field M, Smith KD. Investigation into the concanavalin A reactivity, fucosylation and oligosaccharide microheterogeneity of alpha-1-acid glycoprotein expressed in the sera of patients with rheumatoid arthritis. J Chromatogr B Biomed Sci Appl. 1997;688(2):229–237. doi: 10.1016/s0378-4347(96)00309-x. [DOI] [PubMed] [Google Scholar]
- 108.Havenaar EC, Axford JS, Brinkman-van der Linden EC, Alavi A, Van Ommen EC, van het Hof B, Spector T, Mackiewiczm A, Van Dijk W. Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha-3-fucosylation of alpha-1-acid glycoprotein. Glycoconj J. 1998;15(7):723–729. doi: 10.1023/a:1006944700325. [DOI] [PubMed] [Google Scholar]
- 109.van Gisbergen KPJM, Aarnoudse CA, Meijer GA, Geitjenbeek TBH, van Kooyk Y. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res. 2005;65(13):5935–5944. doi: 10.1158/0008-5472.CAN-04-4140. [DOI] [PubMed] [Google Scholar]
- 110.Cambi A, Koopman M, Figdor CG. How C-type lectins detect pathogens. Cell Microbiol. 2005;7(4):481–488. doi: 10.1111/j.1462-5822.2005.00506.x. [DOI] [PubMed] [Google Scholar]
- 111.Okuyama T, Maehara Y, Kakeji Y, Tsujitani S, Korenaga D, Sugimachi K. Interrelation between tumor-associated cell surface glycoprotein and host immune response in gastric carcinoma patients. Cancer. 1998;82(8):1468–1475. doi: 10.1002/(sici)1097-0142(19980415)82:8<1468::aid-cncr6>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
